Xref Limited (ASX:XF1) Announces H1 FY2025 Business Update
Xref Limited (ASX:XF1) reports a 10% revenue increase in H1 FY2025 and outlines strategic direction following a declined SEEK acquisition offer.
Category: Information Technology
AUCyber Limited (ASX:CYB) Control Shifts to 5GN as Offer Closes
AUCyber Limited (ASX:CYB) control transfers to 5GN with the revised offer scheduled to close on February 17, 2025.
Pro Medicus Limited (ASX:PME) Secures A$53M Contract with BayCare
Pro Medicus Limited (ASX:PME) secures a A$53M, 7-year contract with BayCare to implement its Visage 7 Enterprise Imaging Platform.
Beamtree Holdings Limited (ASX:BMT) Appoints New CEO
Beamtree Holdings Limited (ASX:BMT) appoints Marek Stepniak as new CEO to drive global growth and innovation in the healthcare sector.
Xref Limited (ASX:XF1) Announces Proposed Acquisition by SEEK
Xref Limited (ASX:XF1) proposes a $0.218 per share acquisition by SEEK International Investments, offering significant premium to shareholders.
PARKD Limited (ASX:PKD) Extends Licence Agreement with Fielders Steel Roofing
PARKD Limited (ASX:PKD) extends its licence terms with Fielders Steel Roofing by seven days to finalise agreement on its IP.
Yojee Limited (ASX:YOJ) Announces Q2 FY2025 Activity Report
Yojee Limited (ASX:YOJ) reports Q2 FY2025 activities, highlighting successful deployments, revenue performance, and a positive outlook.
Lithium Energy Limited (ASX:LEL) Announces Amended Solaroz Sale and Axon Graphite Spin-Out
Lithium Energy Limited (ASX:LEL) amends the sale of its Solaroz project and plans to spin out Axon Graphite through a shareholder-approved IPO.
Micro-X Ltd (ASX:MX1) Reports Q4 Strategic Realignment and Financial Highlights
Micro-X Ltd (ASX:MX1) realigns strategy towards Medical CT, secures $25m ARPA-H funding, and achieves key product milestones in Q4.
Echo IQ Limited (ASX:EIQ) Submits Pre-Submission Meeting Request with US FDA
Echo IQ Limited (ASX:EIQ) submits a pre-submission meeting request with the US FDA for its heart failure solution, EchoSolv HF, progressing towards market entry in H2 2025.